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Dear Sirs,
Nummular headache (NH) (or coin-shaped cephalalgia) is
a chronic, mild-to-moderate, pressure-like pain in a small
circumscribed area of the head in the absence of any lesion
of the underlying structures, first described in 2002 [1].
While[200 cases have been reported so far, the treatment
of NH is still a matter of debate. In this report, we describe
a patient with NH who was successfully treated with
Neurotropin (NTP), an analgesic drug currently used in
Japan and China for the treatment of chronic pain
conditions.
A 28-year-old man reported, for *2-month period,
continuous pressure-like pain of mild intensity in a rounded
area 3–4 cm in diameter of the left parietal region. The
pain tended to worsen in intensity during the evening, and
it was accompanied by discomfort and increased sensitivity
to light touch within the same area. No nausea, vomiting,
photophobia, or phonophobia was reported. His past and
family history was unremarkable. He had been taking over-
the-counter analgesics and loxoprofen sodium prescribed
from another hospital with no relief. Neurologic exami-
nation and cerebral computed tomography were normal.
In accordance with International Classification of Head-
ache Disorders (ICHD)-II criteria, a diagnosis of NH was
made. The patient was treated with NTP 16 units/day, which
provided a significant pain relief within the next 2 weeks. He
was followed 12 weeks later and reported that he stopped
taking NTP after 2 months, without recurrence of NH.
NTP, a nonprotein extract from inflamed skin of rabbits
inoculated with vaccinia virus, is widely used in Japan to
treat chronic pain conditions such as lumbago, neck–
shoulder–arm syndrome, fibromyalgia, and postherpetic
neuralgia. In animal models, NTP showed anti-nociceptive
effects via activation of the descending pain inhibitory
pathway [2, 3]. Although it is unclear whether NH repre-
sents a focal, nociceptive-type pain stemming from epi-
cranial tissues or neuralgia of a terminal branch of a
pericranial sensitive nerve [4], the anti-nociceptive action
of NTP seemed beneficial against NH in this patient.
We feel that the present observation adds NTP as a
possible suitable choice of treatment for NH. Further to
corroborate the efficacy of NTP, we hope that the results of
a double-blind study of this agent in complex regional pain
syndrome conducted at the US National Institutes of Health
[5], which are expected shortly, would lead to approval of
NTP in many other countries.
Informed consent for possible publication in The Journal
of Headache and Pain was obtained from the patient.
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